What is the wait period for a patient to see a rheumatologist in your country? Danish laws mandates the wait for a rheumatologist cannot be longer than 4 weeks (either by telemedicine or in person appts). #EULAR2022 @rheumnow https://t.co/TaYysIyGSi

“Tomorrow’s challenge is not to accumulate data, it’s to store, platform, analyse and make the most of these data. It will need to be #digital and #human” @DanielAletaha during the #EULAR2022 opening ceremony @RheumNow

Does AI really help to diagnose RMDs? Well this is the question we will try to answer today. We are waiting for you in Hall D5 for the AI session starting at 2.15pm ✨ @DiegoBenavent @eular_org #EULAR2022 @RheumNow https://t.co/JoKELQKMcE

#EULAR2022 ANCA associated recommendations: Bactrim prophylaxis recommended for patients on RTX, CYC, and/or high dose glucocorticoids 💊 @RheumNow https://t.co/5JvcZpI5jq

#EULAR2022 AAV Reccs Revised: Plasma exchange can be considered for pts with GPA/MPA in pts w/active GN (not for alveolar hemorrhage) @rheumnow https://t.co/zkJljHgly4

Where is overall mattock disease following a covid vaccine range from 4.4 to 14.9% period this study of 4627 showed an 11.7% flare rate within 3 months of VAX #EULAR2022 abtr POS 0200 https://t.co/sxI4791rll

Baricitinib fails in 2 phase 3 lupus trials, BRAVE I & II #EULAR2022 abtr POS 0190 https://t.co/ecGA2A42kP

Voclosporin in lupus nephritis - good 3 year continuation data. #EULAR2022 abtr POS 0186 https://t.co/s4Dj6ZTh71

Bridge Prednisone Use Fails to Improve Outcomes A one year, X-ray outcome trial has shown that the initial use of prednisone (high or low dose) in newly treated active early rheumatoid arthritis (RA) did not improve radiographic outcomes. https://t.co/Ugl05Mljwj https://t.co/zXYYTHE7yW

• https://bit.ly/3PLWN5r

Tuesday Night Rheumatology: HOT TOPICS IN RHEUMATOLOGY https://t.co/tMMrRU3sXa

• https://twitter.com/i/broadcasts/1OyKADemyawxb

NEJM Image: Salt-and-Pepper Skin Changes in Systemic Sclerosis https://t.co/MVjFgMYBoI https://t.co/yIxsEp3xKz

• https://bit.ly/3a6zouN

Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on https://t.co/V10S4oVFsv. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus? https://t.co/RWH0JoHdFA https://t.co/iEtfj5UnEC

• http://RheumNow.com
• https://bit.ly/3a0hAlb